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A 2 days old, 2.7 kg heavy baby boy with critical pulmonary stenosis, underwent successful balloon dilation. After
the uneventful procedure, he remained oxygen dependent. The baby was given oral angiotensin converting enzyme
inhibitor (ACE inhibitor), instead of an infusion of alpha blocker.
Within few hours, in the afternoon of the same day after administration of ACE Inhibitor, the baby could be
weaned off oxygen, maintaining on room air, oxygen saturation between 87% and 92%. At follow-up, two months
later, his saturation was 99% on room air.
We believe that some neonates with critical pulmonary valve stenosis who remain oxygen dependent despite
successful balloon dilation, could benefit from such management.
 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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plasty, will still need more tailored medical atten-
tion. It has been shown that some of these patients
at different times after the intervention can benefit
from the administration of an alpha blocker [1].
In this report we present a 2 day old, 2.7 kg heavy
baby boy with critical pulmonary valve stenosis,
who was successfully and uneventfully ballooned.
The oxygen and duct dependent baby did not need
ventilation. It was elected to do the intervention on
conscious sedation while the anesthesiologist was
in the catheterization laboratory. The pulmonary1016–7315  2011 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
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balloon catheter was used. After successful balloon
dilation as judged by decrease in echo Doppler
gradient, oxygen saturation remained below 80%.
The procedure was uneventful. But after the proce-
dure the baby remained oxygen dependent to
maintain an oxygen saturation of above 85%. As
the baby was not in significant distress we thought
of giving him oral angiotensin converting enzyme
inhibitor (ACE inhibitor), instead of infusion of
the alphablocker [1,3].
Within few hours (Fig. 1) after administration of
ACE Inhibitor, the baby could be weaned off
Figure 1. The dramatic improvement of the oxygen saturation and concomitantly the rapid weaning of oxygen from 30% to room air, few hours
after starting ACE inhibitor.
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uration between 87% and 92%.
We believe that some infants with critical
pulmonary stenosis post successful balloon valvu-
loplasty, can benefit from such management.Case report
A 2 days old (48 cm height, 2.7 kg weight) full
term baby of normal delivery was discovered to
have cyanosis and a systolic murmur 3 h post
delivery. Saturation on room air went down to
65%. He was put on 40% oxygen and on prosta-
glandin (PGE1) 0.02 ugs/kg/min infusion. He did
not need ventilation. On auscultation, there was
a 2/6 continuous murmur. ECG showed sinus
rhythm with biventricular hypertrophy. X-ray of
the chest revealed a small heart with reduced
vascularity.
Echocardiography
Echocardiography diagnosed a critical pulmon-
ary valve stenosis. The tricuspid valve measured
1.2 cm in diameter (z value +0.21) and was compa-
rable with the mitral valve. The patent foramen
ovale (PFO) showed bidirectional shunting. There
was neither tricuspid regurgitation nor stenosis.
Well sized right ventricle with good biventricular
function and intact ventricular septum was ob-
served. The pulmonary valve annulus measured
7 mm with no infundibular stenosis. The peak gra-
dient across the doming pulmonary valve was ele-
vated with 80 mmHg. There was mild to moderate
pulmonary valve regurgitation. In the left aortic
arch, no coarctation with a moderate size PDA
with left to right shunt across it was observed. It
was decided to take the patient to the cardiac cath-eterization laboratory in view of balloon
valvuloplasty.
Cardiac catheterization
Cardiac catheterization was done under con-
scious sedation. The intervention was performed
uneventfully using a 4 Fr sheath through the right
femoral vein. Before balloon dilation the right
ventricular pressure was 121 mmHg, while the
systemic pressure of the baby was 50/45 mmHg,
with a mean of 33 mmHg. The pulmonary artery
pressure was 46/23 with a mean of 35 mmHg.
The maximum gradient between right ventricle
(RV) and pulmonary artery (PA) was 75 mmHg.
The pulmonary valve was gradually ballooned
with a 8 mm, 2 cm long Tyshak balloon catheter
(Numed, Canada). The gradient across the
pulmonary valve after the intervention was
17 mmHg. The RV pressure dropped to 57 mmHg,
while the PA pressure was 40 mmHg. The systemic
pressure at that time remained as the one before
balloon dilation. Fluoroscopy time was 18 min
and the procedure time was 72 min.
The procedure was uneventful and the baby was
sent back to NICU on Prostaglandin infusion and
oxygen mask, in good condition. Prostaglandin
was discontinued due to a misunderstanding be-
tween the pediatric cardiologist and the intensi-
vist. The child remained for the next 2 days
oxygen dependent to maintain acceptable oxygen
saturation on room air of >85%.
Clinical follow-up
As the neonate for two days after the procedure
remained unchanged, was oxygen dependent and
the baby was on oral feed and not on any infusion,
we elected to start him because of his young age on
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CASE REPORTlow dose oral ACE inhibitor (Captopril 0.15 mg/kg/
day). He received 0.3 mg TID. The afternoon of the
same day (<15 h), oxygen supply could be stopped
as the baby was saturating on room air between
87%and 92%, as measured by pulse oxymetry
(Fig. 1).
After two more days of observation, the baby
was sent home on the same dose of oral ACE
inhibitor. He was seen in the clinic two months
later and his weight was now 3.5 kg, his saturation
on room air was 99% on room air. The peak
systolic gradient across the pulmonary valve as
measured by echo Doppler was 37 mmHg with
only mild pulmonary regurgitation. ACE inhibitor
was stopped.Discussion
Based on previous studies it has been shown
that patients with valvar pulmonary stenosis have
increased density and responsiveness of alpha2
adrenoceptors on the circulating cells [2]. After
balloon dilation there is an immediate drop in
these values to normal levels. It was speculated
that alpha2 adrenoceptors on the circulating cells
represent distribution of these receptors on car-
diac, systemic and pulmonary vascular myocytes.
It was further hypothesized that occasionally (for
some unknown reasons) alpha2 adrenoceptors do
not decrease after balloon valvuloplasty and ele-
vated alpha2 receptor activity could explain oxy-
gen desaturation in a subset of these patients
despite apparently having a successful balloon
valvuloplasty [1].
Based on this speculation, phentolamine infu-
sion has been used successfully in two neonates
who remained critically ill after a successful inter-
vention. Phentolamine application improved their
clinical status dramatically [1].
In another case, phentolamine was used to
check whether an alpha2 blocker might also have
a role in the subacute management of such pa-
tients. The patient remained prostaglandin and
oxygen dependent for 2 weeks post successful
pulmonary valvuloplasty. It only started to be
weaned off PGE and oxygen, when phentolamine
was introduced in the regimen. [3]. Before discon-
tinuing phentolamine, oral angiotensin convert-
ing enzyme inhibitor was initiated with the idea
that this medication might have similar effect on
pulmonary vasculature and right ventricular
compliance to that of phentolamine, but through
a different mechanism of action. At least in the
rat model ACE inhibitor has been found to havea role in pulmonary vascular remodeling and
decreasing the pulmonary arterial pressure
through preservation of endothelial nitric oxide
synthase. [5] The action of angiotensin converting
enzyme inhibitor is known to block the conver-
sion of angiotensin I to angiotensin II. As angio-
tensin II is known to lead to vasoconstriction of
the peripheral as well as the pulmonary vascular-
ity, blocking its action, not only lowers arteriolar
resistance and increases venous capacity, but also
can lower the resistance in the pulmonary vascu-
lature. In a study from John Hopkins it has been
shown that angiotensin converting enzyme
inhibition increases bradykinin, an agonist of
Nitric oxide synthase (NOS). Nitric oxide is a well
known vasodilator of the pulmonary vascularity
[6]. Theoretically, by facilitating forward flow into
the lung as well reducing the afterload, by reduc-
ing vasoconstriction in the systemic vessels, all
this could help to increase cardiac output and
hence improve perfusion and overall oxygena-
tion. Interestingly it has been shown that nitric
oxide (NO) modulates cardiac function by abbre-
viating the systolic contraction and leads to an
enhancement of diastolic relaxation and this was
also seen in patients with severe pressure-over-
load hypertrophy. Additionally, NO exerts a
marked decrease in left ventricular end-diastolic
pressure without affecting left ventricular systolic
pump function [4]. This mechanism would facili-
tate the inflow into the right ventricle and also
would add to the noticed improvement of oxy-
genation in our patient.
The action of alpha adrenergic receptors on the
peripheral vessels is to increase vasoconstriction.
Therefore, alpha2 blocker blocks the effect of sym-
pathetic nerves on blood vessels by binding alpha
adrenoceptors located on the vascular smooth
muscle. This will lead to diminishing of this action
and hence will help dilate the vessels. Hence our
statement, that angiotensin converting enzyme
inhibitor has similar effects as alpha blockade
but works on the vessels through different
pathways.
Encouraged by the previous experience [3], in
the underlying case with oxygen dependency in
the absence of major clinical distress and the need
for any infusion, it was decided from the start to
give the patient oral angiotensin converting en-
zyme inhibitor. We were rewarded with the unex-
pected prompt clinical response. The patient
within <15 h of initiation of the medication could
be weaned off oxygen supply completely.
Even though it is an anecdotal observation, all
the different reports suggesting the beneficial
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tor support our hypothesis that this medication
is useful in such a disease.
On the other hand hoping for a controlled study
is most probably very difficult to achieve, as the
disease we are dealing with is extremely rare,
and a control study might take few years to
accomplish.
This report shows that angiotensin converting
enzyme inhibitor might have an important role
in the management of patients with critical pul-
monary stenosis, who remain oxygen dependent
despite successful balloon dilation. It is believed
that using this therapeutic approach as early as
possible in such patients may either shorten their
need for oxygen or even prostaglandin depen-
dency. This might reduce the need for intensive
care and hospital stay, and possibly save them
from any further surgical or catheter intervention.
Of course this will allow the neonates to go home
early and no doubt might even help to reduce
health care costs.References
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